Oncology Times - OncTimes Talk
OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
- Update frequency
- every 4 days
- Average duration
- 13 minutes
- Episodes
- 199
- Years Active
- 2009 - 2025
World-Wide Clinical Perspectives from Chinese Society of Clinical Oncology’s Globally Upscale 2024 Annual Meeting
00:08:21 |
Fri 04 Oct 2024
Breastfeeding After Hormone Receptor-Positive Breast Cancer: No Detectable Risk for Patients
00:11:33 |
Thu 26 Sep 2024
Proton Pump Inhibitors Bigger Impact on Dasatinib Efficacy in CML Than Previously Thought
00:04:31 |
Tue 09 Jul 2024
Immune-Related Adverse Events Predict Response to Checkpoint Inhibitor Monotherapy in Advanced Head & Neck Cancers
00:06:28 |
Tue 09 Jul 2024
A Multi-Drug Algorithm Used to Accurately Predict Best First-Line Treatments in Patients With Newly Diagnosed Acute Myeloid Leukemia
00:07:39 |
Tue 09 Jul 2024
Telehealth Triumphs for Palliative Care Delivery in Patients With Lung Cancer
00:14:15 |
Tue 25 Jun 2024
Lymphadenectomy Can Be Safely Omitted for Patients With Advanced Epithelial Ovarian Cancer Lacking Suspicious Lymph Nodes
00:10:53 |
Tue 25 Jun 2024
Neoadjuvant Checkpoint Inhibitor Combination Beats Standard Surgery With Adjuvant Immunotherapy in Macroscopic, Resectable Stage III Melanoma
00:11:34 |
Tue 25 Jun 2024
Asciminib May Be a Safer, More Effective Treatment for Patients With Newly Diagnosed Chronic Myeloid Leukemia
00:09:25 |
Wed 19 Jun 2024
Chemotherapy Before and After Surgery Improved Outcomes for Patients With Resectable Locally Advanced Esophageal Adenocarcinoma
00:06:52 |
Tue 18 Jun 2024
Trastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine Therapy
00:08:13 |
Tue 18 Jun 2024
Study Supports Osimertinib as Standard of Care for Patients With Locally Advanced EGFR-Mutated NSCLC
00:08:50 |
Tue 11 Jun 2024
Study Finds Durvalumab Improved Progression-Free and Overall Survival in Limited Stage Small Cell Lung Cancer
00:11:34 |
Tue 11 Jun 2024
German Study Finds New Regimen for Hodgkin Lymphoma More Effective, Less Toxic
00:17:36 |
Tue 11 Jun 2024
Kinase Inhibitor Delivers Synthetic Lethality to Enhance Radiotherapy in Glioblastoma
00:10:31 |
Wed 29 May 2024
mRNA Vaccine + Checkpoint Inhibitor Combo Had Low Toxicity With Evidence of Efficacy in Advanced NSCLC
00:08:21 |
Wed 29 May 2024
Disclaimer: The podcast and artwork embedded on this page are the property of Oncology Times. This content is not affiliated with or endorsed by eachpod.com.